Shiyong Neo

5PUBLICATIONS
54CO-AUTHORS
Molecular targetsInnate immunityCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 29, 2026
Nur77 agonism invigorates Natural Killer cell immunity against hepatocellular carcinoma.

|Apr 28, 2025
Adaptive NK Cells Exhibit Tumor-Specific Immune Memory and Cytotoxicity in Ovarian Cancer.

Yizhe Sun, Andrea Rodgers Furones, Okan Gultekin

|May 15, 2024
Tumor-associated NK cells drive MDSC-mediated tumor immune tolerance through the IL-6/STAT3 axis.

Shi Yong Neo, Le Tong, Joni Chong

|Aug 16, 2023
Competing Engagement of β-arrestin Isoforms Balances IGF1R/p53 Signaling and Controls Melanoma Cell Chemotherapeutic Responsiveness.

Sonia Cismas, Sylvya Pasca, Caitrin Crudden

|Apr 26, 2023
Harnessing novel strategies and cell types to overcome immune tolerance during adoptive cell therapy in cancer.

Shi Yong Neo, Shengli Xu, Joni Chong

Pageof 1

Frequent Collaborators

3 joint publications

Kong-Peng Lam

2 joint publications

Shengli Xu

2 joint publications

Le Tong

2 joint publications

Xinsong Chen